Cerus Corporation

Financials

Total assets 221.41 M237.5 M218.09 M197.75 M200.92 M221.86 M Total liabilities 117.61 M151.88 M149.53 M144.3 M144.02 M156.89 M Total equity 103.81 M85.62 M68.56 M53.44 M56.9 M64.97 M Total liabilities & shareholders' equities 221.41 M237.5 M218.09 M197.75 M200.92 M221.86 M Total debt 48.1 M69.42 M69.8 M79.8 M84.16 M83.89 M Net debt -85.49 M-59.94 M-32.35 M13.94 M3.71 M1.01 M

Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry.

CERS

Financials

Cerus Corporation

Haberler

Jensen, Cerus Corp hukuk müdürü, 187 bin dolarlık hisse sattı

Jensen, Cerus Corp chief legal officer, sells $187k in stock

Cerus Corp CFO 211 bin dolarlık hisse sattı

Cerus Corp CEO’su Greenman 742 bin dolarlık hisse sattı

Cerus Corp COO Jayaraman 273 bin dolarlık hisse sattı

Cerus Corp: Tıbbi direktör Benjamin 168 bin dolarlık hisse sattı

Cerus Corp COO Jayaraman sells $273k in shares

Cerus Corp CEO Greenman sells $742k in shares

Cerus Corp: chief medical officer Benjamin sells $168k in shares

Cerus Corp CFO green sells $211k in shares

Cerus names COO Vivek Jayaraman as next CEO effective July 1

Cerus CFO Kevin Green 169 bin dolarlık hisse sattı